Business Practice

The year 2018 will be one of yet more drug approvals, but which areas will be neglected?

Addressing the opioid crisis, 3D printing drug guidelines, and execution drugs…

Sitting Down With… Richard Markus, Vice President of Global Development, Amgen, USA

Can we predict the impact Brexit will have on UK life sciences?

A Spotlight Interview with... Kishor Wasan, Dean of the College of Pharmacy and Nutrition, University of Saskatchewan, Canada.

Iraq war victims accuse several pharma companies of aiding and abetting a terrorist group.

Healthcare Futurist Joe Flower gives his views on how pharma can avoid a dystopian future.

Will AI generate new hypotheses and lead to repurposed failed drug candidates?

A century from now, will healthcare and medicine look like dystopia or utopia?

Sitting Down With… Margaret Hamburg, President-elect AAAS, Foreign secretary of National Academy of Medicine